AR and prostate carcinoma: Similar to NRIP, the percentage of high-AR cases was significantly greater (P < 0.005 for each comparison in Figure 2B) in human prostate cancer (either all tumors or any sub-category with GS ≤ 6, 7, or ≥ 8) than in non-neoplastic prostate tissues (Figure 2B).